Characterization of circulating human osteoclast progenitors: Development of in vitro resorption assay

Calcified Tissue International

Volumn 76, Issue 3, 2005, Pages 222-230

  Husheem, M ^a   Nyman, J K E ^a   Vaaraniemi J ^a   Vaananen, H K ^a   Hentunen, T A ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Bone resorption; Cell surface marker; Immunomagnetic cell separation; Osteoclast formation; Osteoclast progenitor

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ANTIBODY; BAFILOMYCIN A1; CALCITONIN; CARBOXY TERMINAL TELOPEPTIDE; CD11B ANTIGEN; CD14 ANTIGEN; CD61 ANTIGEN; COLONY STIMULATING FACTOR 1; DEXAMETHASONE; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL SEPARATION; CIRCULATION; CONTROLLED STUDY; CULTURE MEDIUM; IMMUNOMAGNETIC SEPARATION; IN VITRO STUDY; MONOCYTE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; STEM CELL; ANIMAL; BIOASSAY; CATTLE; COMPARATIVE STUDY; CULTURE TECHNIQUE; CYTOLOGY; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; STAINING;

ANIMALS; ANTIGENS, CD14; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; BONE RESORPTION; CATTLE; CELL CULTURE TECHNIQUES; CELLS, CULTURED; HUMANS; IMMUNOMAGNETIC SEPARATION; MALE; MONOCYTES; OSTEOCLASTS; STAINING AND LABELING;

EID: 21344437260     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-004-0123-z     Document Type: Article

References (63)

1. Scheven BA, Visser JW, Nijweide PJ (1986) In vitro osteoclast generation from different marrow fractions including a highly enriched haematopoitic stem cell population. Nature 321:79-81
2. Hagenaars CE, van der Kraan AA, Kawilarang-de Haas EW, Visser JW, Nijweide PJ (1989) Osteoclast formation from cloned pluripotent hematopoietic stem cell. Bone Miner 6:179-189
3. Hattersley G, Chambers TJ (1989) Generation of osteoclasts from hematopoietic cell and multipotential cell in vitro. J Cell Physiol 140:478-482
4. Suda T, Takahashi N, Martin TJ (1992) Modulation of osteoclast differentiation. Endoc Rev 13:66-80
5. Matayoshi A, Brown C, DiPersio JF, Haug J, Abu-Amer Y, Liapis H, Kuestner R, Pacifici R (1996) Human blood mobilized hematopoitic precursors differentiate into osteoclasts in the absence of stromal cell. Proc Natl Acad Sci USA 93:10785-10790
6. Walker DG (1973) Osteoporosis cured by temporary parabiosis. Science 180:875
7. Kahn AJ, Simmons DJ (1975) Investigation of the cell lineage in bone using a chimera of chick and quail embryonic tissue. Nature 258:325-327
8. Walker DJ (1975) Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through the use of bone marrow mononuclear phagocytes. J Exp Med 142:651-663
9. Coccia PF, Krivit W, Cervenka J, Clawson C, Kersey JH, Kim TH, Nesbit ME, Ramsay NK, Warkentin PI, Teitelbaum SL, Kahn AJ, Brown DM (1980) Successful bone marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 302:701-708
10. Faust J, Lacey DL, Hunt P, Burgess TL, Scully S, Eli A, Qian Y, Shalhoub V (1999) Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors. J Cell Biochem 72:67-80
11. Chambers TJ (1980) The cellular basis of bone resorption. Clin Orthop 151:283-293
12. Roodman GD (1991) Osteoclast differentiation. Crit Rev Oral Biol Med 2:389-409
13. Fujikawa Y, Quinn JM, Sabokbar A, McGee JO Athanasou NA (1996) The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137:4658-4661
14. Burger EH, Van der Meer JW, Gevel JS, Gribnau JC, Thesingh GW, Furth R van (1982) In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp Med 156:1604-1614
15. Schneider GB, Relfson M (1988) A bone marrow fraction enriched for granulocyte-macrophage progenitors gives rise to osteoclasts in vitro. Bone 9:303-308
16. Kurihara N, Gluck S, Roodman GD (1990) Sequential expression of phenotype markers for osteoclasts during differentiation of precursors for multinucleated cells formed in long-term human marrow cultures. Endocrinology 127:3215-3221
17. Mbalaviele G, Orcel P, Morieux C, Nijweide PJ, de Vernejoul MC (1995) Osteoclast formation from human cord blood mononuclear cells co-cultured with mice embryonic metatarsals in the presence of M-CSF. Bone 16:171-177
18. Cournot G, Petrovic M, Trubert CL, Cormier C, Girault D, Fischer A, Garabedian M (1993) Cultured circulating mononuclear cells from osteopetrotic infants express the osteoclast-associated vitronectin receptor and form multinucleated cells in response to 1,25-dihydroxyvitamin D3. J Bone Miner Res 8:61-70
19. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Rev 20:345-357
20. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM (1999) OPGL is a key regulator of osteoclastogeneis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323
21. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tompyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3697-3602
22. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176
23. Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Yano K, Morinaga T, Higashio K (1998) RANK is essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 253:395-400
24. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T (1998) Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cells culture. Biochem Biophys Res Commun 246:199-204
25. Stanley ER, Guilbert LJ, Tushinski RJ, Bartelmez SH (1983) CSF-1-a mononuclear phagocyte lineage-specific hemopoieric growth factor. J Cell Biochem 21:151-159
26. Tanaka S, Takahashi N, Udagawa N, Tamura T, Akatsu T, Stanley ER, Kurokawa T, Suda T (1993) Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 91:257-263
27. Yang S, Zhang Y, Rodriguiz RM, Ries WL, Key LL Jr (1996) Functions of the M-CSF receptor on osteoclasts. Bone 18:355-360
28. Selander K, Lehenkari P, Vaananen HK (1994) The effects of bisphosphonates on the resorption cycle of isolated osteoclasts. Calcif Tissue Int 55:368-375
29. Fujikawa Y, Quinn JM, Sabokbar A, McGee JO Athanasou NA (1996) The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137:4658-4661
30. Quinn JM, Neale S, Fujikawa Y, McGee JO, Athanasou NA (1998) Human osteoclast formation from blood monocytes, peritoneal macrophages and bone marrow cells. Calcif Tissue Int 62:527-531
31. Shalhoub V, Faust J, Boyle WJ, Dunstan CR, Kelley M, Kaufman S, Scully S, Van G, Lacey DL (1999) Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. J Cell Biochem 72:251-261
32. Nicholson GC, Malakellis M, Collier FM, Cameron PU, Holloway WR, Gough TJ, Gregorio-King C, Kirkland MA, Myers DE (2000) Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin Sci 99:133-140
33. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A (2000) Tumor necrosis factor-a induces differentiation and bone resorption by osteoclasts. J Biol Chem 275:4858-4864
34. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481-1488
35. Jimi E, Shuto T, Koga T (1995) Macrophage colony-stimulating factor and interleukin-1a maintain the survival of osteoclast-like cells. Endocrinology 136:808-811
36. Sarma U, Flanagan AM (1996) Macrophage-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures. Blood 88:2531-2540
37. Hirayama T, Sabokbar A, Athanasou NA (2002) Effect of corticosteroids on human osteoclast formation and activity. J Endocrinol 175:155-163
38. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of ODF/RANKL-RANK-interaction. J Exp Med 191:257-286
39. Shalhoub V, Elliott G, Chiu L, Manoukian R, Kelley M, Hawkins N, Davy E, Shimamoto G, Beck J, Kaufman SA, Scully S, Qi M, Grisanti M, Dunstan C, Boyle WJ, Lacey DL (2000) Characterization of osteoclast precursors in human blood. Br J Haematol 111:501-512
40. Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R (2001) T cell activation induces human osteoclast formation via receptor activator of nuclear factor κB ligand-dependent and -independent mechanisms. J Bone Miner Res 16:328-337
41. Shuto T, Kukita T, Hirata M, Jimi E, Koga T (1994) Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures. Endocrinology 134:1121-1126
42. Kaji H, Sugimoto T, Kanatani M, Nishiyama K, Chihara K (1997) Dexamethasone stimulates osteoclast-like cell formation by directly acting on hemopoietic blast cells and enhances osteoclast-like cell formation stimulated by parathyroid hormone and prostaglandin E2. J Bone Miner Res 12:734-741
43. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S (1999) Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382-4389
44. Hasegawa T, Yoshimura Y, Kikuiri T, Yawaka Y, Takeyama S, Matsumoto A, Oguchi H, Shirakawa T (2002) Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells. J Periodontal Res 37:405-411
45. Hasegawa T, Kikuiri T, Takeyama S, Yoshimura Y, Mitome M, Oguchi H, Shirakawa T (2002) Human periodontal ligament cells derived from deciduous teeth induce osteoclastogenesis in vitro. Tissue Cell 34:44-51
46. Huang L, Xu J, Kumta SM, Zheng MH (2001) Gene expression of glucocorticoid receptor alpha and beta in giant cell tumour of bone: evidence of glucocorticoid-stimulated osteoclastogenesis by stromal-like tumour cells. Mol Cell Endocrinol 181:199-206
47. Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ (2000) Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Bone Miner Res 15:1459-1466
48. Kudo O, Sabokbar A, Pocock A, Itonaga I, Athanasou NA (2002) Isolation of human osteoclast formed in vitro: Hormonal effects on bone resorbing activity of human osteoclasts. Calcif Tissue Int 71:539-546
49. James IE, Lark MW, Zembryki D, Lee-Rykaczewski EV, Hwang SM, Tomaszek TA, Belfiore P, Gowen M (1999) Development and characterization of a human in vitro resorption assay: demonstration of utility using novel antiresorptive agents. J Bone Miner Res 14:1562-1569
50. 1 abolishes bone resorption. Biochem Biophys Res Commun 168:309-313
51. Suda K, Woo JT, Takami M, Sexton PM, Nagai K (2002) Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. J Cell Physiol 190:101-108
52. Quinn JM, Elliott J, Gillespie MT, Martin TJ (1998) A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139:4424-4427
53. Shiohara M, Gombart AF, Sekiguchi Y, Hidaka E, Ito S, Yamazaki T, Koeffler HP, Komiyama A (2004) Phenotypic and functional alterations of peripheral blood monocytes in neutrophil-specific granule deficiency. J Leukoc Biol 75:190-197
54. Athanasou NA, Alvarez JI, Ross FP, Quinn JM, Teitelbaum SL (1992) Species differences in the immunophenotype of osteoclasts and mononuclear phagocytes. Calcif Tissue Int 50:427-432
55. Steiniger B, Barth P, Herbst B, Hartnell A, Crocker PR (1997) The species-specific structure of microanatomical compartments in the human spleen: strongly sialoadhesin-positive macrophages occur in the perifollicular zone, but not in the marginal zone. Immunology 92:307-316
56. Massey HM, Flanagan AM (1999) H. Massey, A. Flanagan, Human osteoclasts derive from CD14-positive monocytes. Br J Haematol 106:167-170
57. Mangham DC, Scoones DJ, Drayson MT (1993) Complement and the recruitment of mononuclear osteoclasts. J Clin Pathol 46:517-521
58. Helfrich MH, Nesbitt SA, Horton MA (1992) Integrins on rat osteoclasts: characterization of two monoclonal antibodies (F4 and F11) to rat beta 3. J Bone Miner Res 7:345-351
59. Athanasou NA, Quinn J, McGee JO (1988) Immunocytochemical analysis of the human osteoclast: phenotypic relationship to other marrow-derived cells. Bone Miner 3:317-333
60. Erices A, Conget P, Minguell JJ (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235-242
61. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93:229-240
62. Fernandez Pujol B, Lucibello FC, Gehling UM, Lindemann K, Weidner N, Zuzarte ML, Adamkiewicz J, Elsasser HP, Muller R, Havemann K (2000) Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65:287-300
63. Komi J, Lassila O (2000) Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells. Blood 95:2875-2882